SuperworthSotera Health price to sales ratio SHC
Market value divided by revenue over the last twelve months, since 2022.
- Today, Oct 23, 2026
- 4.2×
- 5-year median
- 4.1×
- Against its 5-year history
- 59th
- percentile: 0 is its lowest day, 100 its highest
- 5-year range
- 1.7× to 6.7×
- Peer median
- 1.6×
Sotera Health's price to sales ratio is 4.2× as of Oct 23, 2026.
That is above its 5-year median of 4.1×, close to the middle of its last 5 years.
Over that time it ranged from 1.7× in Nov 2022 to 6.7× in Apr 2022.
The median for 10 hospital and care facility stocks of a similar size is 1.6×.
Price to sales ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 4.2× | 3.2× | 4.7× |
| 2025 | 4.4× | 2.7× | 4.4× |
| 2024 | 3.4× | 2.9× | 4.8× |
| 2023 | 4.8× | 2.4× | 5.4× |
| 2022 | 2.4× | 1.7× | 6.7× |
Against its peers
Companies in Medical - Care Facilities nearest Sotera Health's size, closest first, today.
| Company | Price to sales ratio |
|---|---|
| SHCSotera Health | 4.2× |
| CONConcentra Group Holdings Parent | 2.2× |
| LFSTLifeStance Health | 3.1× |
| OPCHOption Care Health | 0.8× |
| CHEChemed | 2.6× |
| NHCNational Healthcare | 2.4× |
| PACSPACS | 1.4× |
| AVAHAveanna Healthcare | 1.1× |
| PRVAPrivia Health | 1.2× |
| ENSGEnsign | 1.9× |
| UHSUniversal Health Services | 0.6× |
| Peer median | 1.6× |
Where Sotera Health ranks
What the price to sales ratio tells you
Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.
Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.
More on Sotera Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.